Medicine – Scientific American

The pandemic is no excuse to abandon chronic disease management and prevention

Despite conflicting data, the highly anticipated results will make the treatment a standard of care in the United States

April 30, 2020 — Heidi Ledford and Nature magazine

Amyloid, the leading target for dementia therapy, faces skepticism after drug failures

April 29, 2020 — Tanya Lewis

Candidates are speeding toward human trials

April 29, 2020 — Charles Schmidt

With politicians touting the potential benefits of malaria drugs to fight COVID-19, some people are turning away from clinical trials of other therapies

April 28, 2020 — Heidi Ledford and Nature magazine

Recent epidemics provide clues to ways the current crisis could stop

April 28, 2020 — Lydia Denworth

Compassionate use of experimental medicine needs to coexist with scientific rigor to help patients, researchers write in the journal Science

April 24, 2020 — Anna Kuchment

With no time to make treatments from scratch, researchers search for existing compounds that deflect harm

April 23, 2020 — Michael Waldholz

Support grows for a controversial ‘human challenge’ vaccine study—but no trial is yet planned

April 22, 2020 — Ewen Callaway and Nature magazine

Research into the brain’s protein-disposal systems, electrical activity and three other areas looks promising

April 22, 2020 — Kenneth S. Kosik

Many hospitalized victims are developing potentially lethal secondary coinfections such as bacterial pneumonia and sepsis

Numerous contenders—from a controversial malaria medication to treatments that regulate the immune system—are now in clinical trials

April 16, 2020 — Tanya Lewis

In mice, a test for lung cancer involves nanoprobes that recognize tumors and send reporter molecules into the urine for simple analysis.

April 15, 2020 — W. Wayt Gibbs

A new era for Alzheimer’s and journalism in the time of coronavirus 

April 14, 2020 — Curtis Brainard

Originally published in June 1954

April 13, 2020

Slated for human trials, EIDD-2801 could become the first pill for COVID-19

April 7, 2020 — Michael Waldholz

Originally published in June 1868

April 7, 2020

Fighting the disease is like trying to hit a moving target, evolutionarily speaking

From online journal clubs to “tweetorials” to conference updates, social media is changing the dissemination and discussion of biomedicine

April 1, 2020 — Nicole Wetsman and Nature Medicine